[ad_1] RT @ThomasCiullaMD: Just published…Understanding the #genetic basis for this common cause of #vision loss will facilitate early detection… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1] Just published-With clinical trials from small molecules to #genetherapy to viral nanoparticles, for disorders from #macular edema to #AMD to #diabeticretinopathy to choroidal melanoma, an understanding of #suprachoroidal drug delivery becomes essential… https://t.co/4qIjnVZ9RP [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1]
Just published…Understanding the #genetic basis for this common cause of #vision loss will facilitate early detection, prognosis & treatment, perhaps even a #PrecisionMedicine approach like #gene therapy someday:
#eyes #glaucoma #Ophthalmology #biotech
https://t.co/1REz7x85tQ
[ad_2]
Source by Thomas Ciulla, MD, MBA
[ad_1] RT @ThomasCiullaMD: Honored to present on Suprachoroidal Drug Delivery & Clearside’s preclinical and clinical research programs at the rece… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1] RT @ThomasCiullaMD: Just published on suprachoroidal drug delivery: “Clinical Characterization of Suprachoroidal Injection Procedure Utiliz… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1]
RT @ThomasCiullaMD: Honored to be listed here and thankful for those patients, colleagues & mentors who inspire us…
[ad_2]
Source by Thomas Ciulla, MD, MBA
[ad_1] RT @ThomasCiullaMD: Pleased to work with Vestrum on clinical data analytics… https://t.co/4uIFiCI2NM [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1] I have great fun & satisfaction mentoring @IU_Health residents interested in #research. Congrats to this fantastic IU team for this publication: Efficacy and safety of bromfenac 0.075% formulated in DuraSite for pain and inflammation in cataract surgery https://t.co/PfF6mJp20p [ad_2] Source by Thomas Ciulla, MD, …
[ad_1]
RT @ThomasCiullaMD: Recently published on a leading cause of #vision loss. #Diabetic macular edema treatment burden remains a significant…
[ad_2]
Source by Thomas Ciulla, MD, MBA
[ad_1] RT @ThomasCiullaMD: Our study highlighted in @RetinalPhys – #Suprachoroidal delivery is of interest given #clinicaltrials of corticosteroid… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.